DoseRAD2026: A benchmark dataset for AI‐accelerated photon and proton dose calculation in radiotherapy
PURPOSE: Accurate dose calculation is a fundamental component of modern radiotherapy, enabling precise tumor irradiation while sparing surrounding healthy tissue. With the increasing adoption of magnetic resonance imaging (MRI)-guided radiotherapy and growing interest in real-time adaptive radiotherapy, there is a demand for fast and accurate dose calculation techniques on both computed tomography (CT) and MRI. To facilitate research in this area, the DoseRAD2026 dataset and accompanying challenge introduce a publicly available benchmark dataset comprising paired CT and MRI data with corresponding beam-level photon and proton Monte Carlo (MC) dose distributions, enabling the development and systematic evaluation of advanced dose calculation and prediction methods. ACQUISITION AND VALIDATION METHODS: The DoseRAD2026 dataset comprises paired CT and MRI data from 115 patients (75 training, 40 testing) treated on a hybrid MRI-linear accelerator (MRI-linac) for thoracic or abdominal lesions and is derived from the SynthRAD2025 dataset. Image pre-processing included deformable image registration, air-cavity correction and resampling. Ground-truth photon (6 MV) and proton dose distributions were generated using open-source MC dose calculation algorithms and resulted in a training dataset of 40,500 photon beams and 81,000 proton beamlets. DATA FORMAT AND USAGE NOTES: The dataset is organized into photon and proton subsets, each comprising paired CT-MRI images, beam-level dose distributions, and JSON files specifying patient-specific beam configurations. Data are provided in compressed MetaImage (.mha) format with standardized naming linking dose files to beam parameters in the JSON files. The dataset is released under a CC BY-NC 4.0 license, with the training set available from April 2026 and the test set withheld until March 2030. POTENTIAL APPLICATIONS: The DoseRAD2026 dataset enables benchmarking and development of fast dose calculation methods for radiotherapy applications. Potential use cases include rapid beam-level dose estimation for photon and proton therapy, MRI-based dose calculation in MRI-only and MRI-guided radiotherapy workflows, and support for real-time adaptive radiotherapy strategies.
Authors
- Adrian Thummerer (ORCID: https://orcid.org/0000-0002-1874-5030)
- Lennart Volz (ORCID: https://orcid.org/0000-0003-0441-4350)
- Matteo Maspero (ORCID: https://orcid.org/0000-0003-0347-3375)
- Zoltán Perkó (ORCID: https://orcid.org/0000-0002-0975-4226)
- G. Dedes (ORCID: https://orcid.org/0000-0003-0071-513X)
- Christopher Kurz (ORCID: https://orcid.org/0009-0005-5565-4591)
- Muheng Li (ORCID: https://orcid.org/0000-0002-0619-5780)
- Niklas Wahl (ORCID: https://orcid.org/0000-0002-1451-223X)
- Guillaume Landry (ORCID: https://orcid.org/0000-0003-1707-4068)
- Viktor Rogowski
- Fan Xiao (ORCID: https://orcid.org/0000-0002-7502-0730)
- Miguel A. Palacios (ORCID: https://orcid.org/0000-0002-8687-5988)
- Nikolaos Delopoulos (ORCID: https://orcid.org/0009-0009-3726-6535)
- Samir Schulz
- Lina Bucher
- Ye Zhang (ORCID: https://orcid.org/0000-0003-1608-4467)
Institutions
- Karlsruhe Institute of Technology (DE)
- University of Bern (CH)
- Bern University of Applied Sciences (CH)
- GSI Helmholtz Centre for Heavy Ion Research (DE)
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital of Bern (CH)
- University Hospital Heidelberg (DE)
- Paul Scherrer Institute (CH)
- University Medical Center Utrecht (NL)
- LMU Klinikum (DE)
- Skåne University Hospital (SE)
- Cancer Center Amsterdam (NL)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
- Vrije Universiteit Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Delft University of Technology (NL)
Publication Details
- Journal
- Medical Physics
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1002/mp.70714
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsches Krebsforschungszentrum
- Deutsche Forschungsgemeinschaft
- China Scholarship Council